FDA 执法报告 D-0113-2027:MSN Laboratories Unit-II 阿托伐他汀钙片因混入外来片剂或胶囊被定为 II 类召回
FDA drug enforcement D-0113-2027: MSN Laboratories Private Limited (Formulations Division, Unit-II) — Presence of Foreign Tablets/Capsules
FDA 执法报告 D-0113-2027 将 MSN Laboratories Private Limited 制剂部 Unit-II 生产的阿托伐他汀钙片 40mg 定为 II 类召回,原因为混入外来片剂或胶囊。
FDA drug recall enforcement report — D-0113-2027
Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "Survey # 1277, 1319-1324",
"address_2": "Nandigama (Village & Mandal)",
"center_classification_date": "20261029",
"city": "Rangareddy District",
"classification": "Class II",
"code_info": "Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.",
"country": "India",
"distribution_pattern": "Nationwide in the USA.",
"event_id": "100172",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA211933"
],
"brand_name": [
"ATORVASTATIN CALCIUM"
],
"generic_name": [
"ATORVASTATIN CALCIUM"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Novadoz Pharmaceuticals LLC"
],
"package_ndc": [
"72205-022-30",
"72205-022-90",
"72205-022-05",
"72205-022-99",
"72205-023-30",
"72205-023-90",
"72205-023-05",
"72205-023-99",
"72205-024-30",
"72205-024-90",
"72205-024-05",
"72205-024-99",
"72205-025-30",
"72205-025-90",
"72205-025-05",
"72205-025-99"
],
"product_ndc": [
"72205-022",
"72205-023",
"72205-024",
"72205-025"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"ORAL"
],
"rxcui": [
"259255",
"617310",
"617311",
"617312"
],
"spl_id": [
"11823aa6-547f-4c0b-983a-65b837f94e89"
],
"spl_set_id": [
"bc448f40-421c-490f-8c39-fa8135507973"
],
"substance_name": [
"ATORVASTATIN CALCIUM TRIHYDRATE"
],
"unii": [
"48A5M73Z4Q"
],
"upc": [
"0372205025905",
"0372205025059",
"0372205024052"
]
},
"postal_code": "N/A",
"product_description": "Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99",
"product_quantity": "13,296 1,000-count bottles",
"product_type": "Drugs",
"reason_for_recall": "Presence of Foreign Tablets/Capsules",
"recall_initiation_date": "20261021",
"recall_number": "D-0113-2027",
"recalling_firm": "MSN Laboratories Private Limited (Formulations Division, Unit-II)",
"report_date": "20261104",
"state": "",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov